TIM3+ cells in gastric cancer: clinical correlates and association with immune context-Reference-Cited by-同舟云学术

TIM3+ cells in gastric cancer: clinical correlates and association with immune context

Published:2021-11-01 Issue:1 Volume:126 Page:100-108
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Chen Ke,Gu Yun,Cao Yifan,Fang Hanji,Lv Kunpeng,Liu Xin,He Xudong,Wang Jieti^ORCID,Lin Chao,Liu Hao,Zhang Heng,He Hongyong,Xu Jiejie^ORCID,Li He,Li Ruochen^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-021-01607-3.pdf

Reference39 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. https://doi.org/10.3322/caac.21492.

2. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49. https://doi.org/10.1016/s1470-2045(10)70070-x.

3. De Vita F, Orditura M, Matano E, Bianco R, Carlomagno C, Infusino S, et al. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. Br J Cancer. 2005;92:1644–9. https://doi.org/10.1038/sj.bjc.6602573.

4. Nishida T. Adjuvant therapy for gastric cancer after D2 gastrectomy. Lancet. 2012;379:291–2. https://doi.org/10.1016/s0140-6736(11)61928-4.

5. Noh SH, Park SR, Yang HK, Chung HC, Chung IJ, Kim SW, et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol. 2014;15:1389–96. https://doi.org/10.1016/s1470-2045(14)70473-5.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and prognostic value of CD44v9 and TIM3 expression in CK^‑ and CK⁺ regions in gastric cancer tissues;Oncology Letters;2024-08-06

2. New Approaches in Gastric Cancer Immunotherapy;Gastric Cancer - Progress and Challenges in the Era of Precision Medicine [Working Title];2024-07-01

3. CircPVT1 promotes migration and invasion by regulating miR‐490‐5p/HAVCR2 axis in osteosarcoma cells;Journal of Cellular and Molecular Medicine;2024-04

4. Emerging insights into keratin 7 roles in tumor progression and metastasis of cancers;Frontiers in Oncology;2024-01-08

5. Prognostic value of T cell immunoglobulin and mucin-domain containing-3 expression in upper gastrointestinal tract tumors: A meta-analysis;World Journal of Gastrointestinal Oncology;2023-12-15